Search clinical trials for: SENS-218

Total 4550 results

Simbec Research
Sensorion SA

Completed

A Single Dose PK Study of SENS-218 in Healthy Volunteers

Inner Ear Diseases
Addpharma Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of AD-218

Mixed Dyslipidemia

Korea, Republic of
Attikon Hospital

Completed

TENS of MENS for Rotator Cuff Tear

Rotator Cuff Tear

Greece
Fuda Cancer Hospital, Guangzhou

Completed

PENS or TENS for Pain in Pancreatic Cancer

Pain | Pancreatic Cancer | Cancer Pain

China
Fuda Cancer Hospital, Guangzhou

Completed

PENS or TENS for Pain in Liver Cancer

Pain | Liver Neoplasms | Cancer Pain

China
Siemens Molecular Imaging

Terminated

Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects

Breast Cancer

United States
Johnson & Johnson Vision Care, Inc.

Completed

Evaluating Soft Contact Lens Prototypes for Myopia Control

Visual Acuity

China
Foundation for Innovative New Diagnostics, Switzerland

Recruiting

BGM and HbA1c POC Device Evaluation

Diabetes

Nigeria, Cambodia, Colombia
University Health Network, Toronto

Active, not recruiting

Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors

Neuroendocrine Tumors

Canada
University of Seville

Completed

Neuromodulation in Professional Dancers

Rehabilitation | Sports Physical Therapy | Dance | Sport Performance

Spain
National Cancer Institute (NCI)

Completed

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery

Refractory Pancreatic Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2

United States
Laboratoires Vivacy

Recruiting

Study of a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face (FaceHyal) (FaceHyal)

Aging | Aesthetics | Volume Deficiency in the Mid-Face

France
Hospital General Universitario Elche

Completed

Weight Loss and Appetite Reduction After Percutaneous Electrical Stimulation Dermatome T6

Weight Loss
Avid Radiopharmaceuticals

Terminated

A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 (T808)

Alzheimers Disease

United States
Sensorion

Completed

Efficacy of SENS-111 in Patients Suffering From Acute Unilateral Vestibulopathy

Acute Unilateral Vestibulopathy (AUV)

United States, Israel, France, Korea, Republic of, Hungary, Germany, Czechia, Italy
Avid Radiopharmaceuticals

Terminated

A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807

Alzheimers Disease | AD

United States
University Hospital Inselspital, Berne
Swiss National Science Foundation; University of Bern

Unknown

A Structured Early Palliative Care Intervention for Patients With Advanced Cancer - a Randomized Controlled Trial With a Nested Qualitative Study (SENS Trial) (SENS)

Advanced Cancer

Switzerland
AnHeart Therapeutics Inc.

Recruiting

IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor

Cholangiocarcinoma With IDH1 Mutation | Solid Tumors With IDH1 Mutation

China
Universidad Rey Juan Carlos

Recruiting

Percutaneous Neuromuscular Electrical Stimulation in Patients With Chronic Low Back Pain (PNMESlowback)

Low Back Pain

Spain
Sensorion

Not yet recruiting

A Phase I/II Clinical Trial With SENS-501 in Children Suffering From Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations (AUDIOGENE)

Otorhinolaryngologic Diseases | Ear Diseases | Hearing Disorders | Deafness | Hearing Loss, Sensorineural | Congenital Deafness | DFNB9 | OTOF Gene Mutation

France
University Hospital, Montpellier

Recruiting

Evaluation of Mobility in Subjects With Severe Knee Osteoarthritis Who Are to Undergo Total Knee Replacement (MOUV-GOPRO)

Knee Osteoarthritis

France
National Cancer Institute (NCI)

Completed

Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer

Recurrent Lung Squamous Cell Carcinoma | Stage IV Lung Squamous Cell Carcinoma AJCC v7

United States
Simbec Research
Sensorion

Completed

A Study of SENS 401 in Healthy Subjects

Inner Ear Disease

United Kingdom
National Cancer Institute (NCI)

Active, not recruiting

Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia

Recurrent Adult Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Refractory Adult Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | T Acute Lymphoblastic Leukemia

United States
Pamukkale University

Completed

Evaluation of Joint Position Sense in Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

Turkey
Odense University Hospital
University of Southern Denmark; Vejle Hospital; Region of Southern Denmark; Gig...

Recruiting

Motivational Feedback Following Total or Unicompartmental Knee Arthroplasty (KneeActivity)

Knee Arthropathy

Denmark
National Cancer Institute (NCI)

Terminated

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

High Grade Sarcoma | Metastatic Leiomyosarcoma | Stage III Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Unresectable Leiomyosarcoma | Myxofibrosarcoma | Metastatic Malignant Peripheral Nerve Sheath Tumor | Metastatic Synovial Sarcoma | Metastatic Undifferentiated... and other conditions

United States
Avid Radiopharmaceuticals

Completed

Augmenting Flortaucipir Dosimetry Estimates

Alzheimer's Disease

United States
Sensorion

Completed

Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss (AUDIBLE-S)

Severe Sudden Sensorineural Hearing Loss

Israel, United Kingdom, France, Serbia, Bulgaria, Canada, Czechia, Germany, Slovakia, Turkey
AnHeart Therapeutics Inc.

Recruiting

Safusidenib Phase 2 Study in IDH1 Mutant Glioma

Glioma

United States
Avid Radiopharmaceuticals

Completed

18F-AV-1451 Autopsy Study

Alzheimer's Disease

United States, Australia
Avid Radiopharmaceuticals

Completed

Tau Screening Study in Patients With Early Symptomatic AD

Alzheimer Disease

United States, Canada
Avid Radiopharmaceuticals

Completed

Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease

Alzheimer Disease

United States
National Cancer Institute (NCI)

Terminated

Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma

Glioblastoma | Gliosarcoma

United States
Coopervision, Inc.

Completed

A Dispensing Clinical Trial of Test Contact Lens Against Marketed Contact Lens

Myopia

United States
Johnson & Johnson Vision Care, Inc.

Completed

Evaluating Accommodative Responses of Soft Contact Lenses for Myopia Control

Visual Acuity

United States
IRCCS Azienda Ospedaliera Universitaria San Martino...

Completed

Exclusive Intraoperative Radiation Therapy for Breast Cancer

Breast Neoplasms | Toxicity

Italy
Avid Radiopharmaceuticals

Completed

Tau Screening Study in Subjects With Early Symptomatic AD

Alzheimer Disease

United States
Coopervision, Inc.

Completed

To Evaluate The Performance Of Two Monthly Replacement Silicone Hydrogel Contact Lenses After 1-month Of Wear

Myopia

Canada
Coopervision, Inc.

Completed

Clinical Evaluation of Two Silicone Hydrogel Contact Lenses

Myopia

United Kingdom
Coopervision, Inc.

Completed

Evaluation of the Performance of Monthly Replacement Sphere Lens Designs in Habitual Soft Contact Lens Wearers

Myopia | Hyperopia

United States
University of Sao Paulo General Hospital

Completed

Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome

Overactive Bladder Syndrome

Brazil
Coopervision, Inc.
CORE

Completed

Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use

Ametropia

United States, Canada
Aier School of Ophthalmology, Central South University

Unknown

Comparison of the Visual Performance After Implantation of Multifocal Lens

Intraocular Lens

China
National Cancer Institute (NCI)

Recruiting

Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer

Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Leptomeningeal Neoplasm | Recurrent Lung Non-Small Cell Carcinoma

United States
Mayo Clinic

Withdrawn

Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography (PEM-FES)

Breast Neoplasm

United States
Avid Radiopharmaceuticals

Completed

Flortaucipir PET Imaging in Subjects With FTD

Frontotemporal Dementia

United States
Avid Radiopharmaceuticals

Completed

Clinical Evaluation of Flortaucipir F 18

Depression | Traumatic Brain Injury | Alzheimer's Disease

United States
National Cancer Institute (NCI)

Active, not recruiting

Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations

Recurrent Bladder Carcinoma | Metastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Bladder Urothelial Carcinoma | Metastatic Transitional Cell Carcinoma

United States
National Yang Ming University

Recruiting

Effects of TENS on Pain Threshold and Brain Activities in Healthy Adults

Electroencephalography | Transcutaneous Electrical Nerve Stimulation | Pressure Pain Threshold

Taiwan

Search clinical trials for: SENS-218

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations